Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
The most effective method to Pick the Right Old Consideration Administration: Key Contemplations - 2The Best Computer games Ever
- 3Car Investigation: A Survey of \Past the Outside\ Car
- 4NASA counts down for first crewed lunar mission in half a century
- 5A definitive Manual for Internet Mastering and Expertise Improvement
- New research reveals urban raccoons across the US show early signs of domestication
- Innospace's rocket crashes in first commercial launch in Brazil; shares tumble
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Defeating An inability to embrace success in Scholarly world: Individual Victories
- Gulf aluminum output tumbles on Iran war
- A Manual for Pick High Evaluated Food Conveyance Administrations In Significant Urban communities For 2024
- Mossad unveils network of Hamas terror infrastructure across Europe
- The Delight of Camper Vans: Choosing the One That Meets Your Requirements
- Watch India launch advanced military satellite on rocket's 1st flight since May 2025 failure
